Natco Pharma has launched generic version of Posaconazole Injection, 300 mg/16.7ml, under its brand POSANAT. It may be noted, the drug is available for the first time in India. It will available in 18 .0 mg/ml strength, a formulation for intravenous (IV) use. Posaconazole Injection is sold in the USA market by Merck under its brand name of NOXAFIL. The drug is an antifungal agent & used in patients who are at high risk of developing infections due to being severely immunocompromised, such as associated with stem cell transplant or from chemotherapy.
Company Profile : Natco Pharma Ltd
Leave a Reply